NCT01938690

Brief Summary

Approximately two thirds of stroke survivors have profoundly impaired function of the upper limb. Currently the main stay of the treatment for upper limb motor function is rehabilitation therapy focusing on repetitive and skillful task practice (task-oriented therapy) which has been shown to induce substantial functional reorganization in the undamaged motor cortex and functional recovery. In spite of rehabilitation therapy, functional recovery of arm and hand function is limited to one third of stroke survivors and there is a great need for adjunct treatment to current practice. Repetitive Transcranial Magnetic Stimulation (rTMS) is a noninvasive means of stimulating nerve cells in superficial areas of the brain and emerging as a novel method of modulating cortical excitability and promoting functional recovery after stroke. There have been studies using rTMS to improve motor function after stroke. However, whether 1Hz rTMS can enhance the effect of the task-oriented therapy on upper limb function after stroke has not been investigated. In this pilot proposal, we intend to investigate the feasibility of 1Hz rTMS on unaffected hemisphere as an adjunct to task-oriented therapy to improve upper limb motor function among stroke patients. The information obtained from this pilot study will provide a platform for the future randomized control trials combining the rTMS and task-oriented therapy to enhance motor recovery among stroke survivors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Feb 2013

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2013

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

September 5, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 10, 2013

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

February 17, 2021

Status Verified

February 1, 2021

Enrollment Period

7 months

First QC Date

September 5, 2013

Last Update Submit

February 16, 2021

Conditions

Keywords

stroke, transcranial magnetic stimulation, rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Upper limb function (Fugl Meyer score)

    6 months

Study Arms (2)

Sham stimulation

SHAM COMPARATOR

Sham stimulation on the scalp of unaffected brain

Device: Transcranial magnetic stimulation (TMS)

transcranial magnetic stimulation

EXPERIMENTAL

transcranial magnetic stimulation on unaffected brain

Device: Transcranial magnetic stimulation (TMS)

Interventions

8 sessions of TMS followed by task specific training

Sham stimulationtranscranial magnetic stimulation

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years of age
  • Ability to give informed consent
  • An unilateral ischemic stroke of onset 6-36 months prior to the study
  • No other known brain abnormalities by medical history or by MRI
  • Affected upper limb function of score 2-6 in Chedoke Arm and Hand Inventory
  • Enrolled or planned to be enrolled in occupational therapy at Kessler Institute for Rehabilitation as an outpatient

You may not qualify if:

  • History of epilepsy or unprovoked seizures
  • Family history of epilepsy (father, mother, children, siblings with diagnosis of epilepsy)
  • Implanted medical devices (pacemakers, defibrillators, medical pump, implanted brain stimulator, aneurysm clip, carotid or cerebral stents, central venous catheter, cochlear implant, internal hearing aids)
  • Damaged skin or skull of head
  • Excessive spasticity of upper limb as indicated by Modified Ashworth Spasticity Scale \>2/4
  • Recent injection of antispastic medications (Botulinum toxin, phenol) of the last 3 months or scheduled such injection during the study period
  • Severe sensory deficits as measured by a score of 2 on item 8 of the National Institute of Health (NIH) stroke scale
  • Severe aphasia as measured by a score of ≥2 on item 9 of NIH stroke scale
  • Being determined to be medically unstable by a physician
  • Being pregnant or trying to become pregnant
  • Past or current alcohol abuse, illicit drug use, or significant mental illness (schizophrenia, major depression, manic disorders)
  • Working with metal currently or in the past
  • Tattoo with metal based ink on the head or neck
  • Unable to answer the questionnaires in the consent form correctly

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kessler Foundation

West Orange, New Jersey, 07052, United States

Location

MeSH Terms

Conditions

Stroke

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Officials

  • A.M. Barrett, MD

    Kessler Foundation

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director Stroke Lab

Study Record Dates

First Submitted

September 5, 2013

First Posted

September 10, 2013

Study Start

February 1, 2013

Primary Completion

September 1, 2013

Study Completion

December 1, 2013

Last Updated

February 17, 2021

Record last verified: 2021-02

Locations